F Repligen Corp Transaction History

F

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$165.87 - $220.95 $1.74 Million - $2.32 Million	-10,482 Closed	0 $0
Q1 2021 Jun 01, 2021	BUY	$180.37 - $226.26 $1.69 Million - $2.12 Million	9,366 Added 839.25%	10,482 $2.04 Million
Q4 2020 Feb 16, 2021	BUY	$148.08 - $206.57 $165,257 - $230,532	1,116 New	1,116 $214,000

496

53.9M

420K

85.3K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of F, based on Form 13F filings with the SEC.

Stay updated on F with notifications on news.